Last update 14 Jul 2025

ARD-103

Overview

Basic Info

Drug Type
CAR-T
Synonyms
ARD 103, ARD103
Target
CLL-1
Action
inhibitors
Mechanism
CLL-1 inhibitors(C-Type lectin domain family 12 member A inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Myelodysplastic SyndromesRelapsing acute myeloid leukemiaAcute Myeloid Leukemia
Inactive Indication-
Originator Organization
Arce Therapeutics, Inc.
Active Organization
Arce Therapeutics, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

1
Clinical Trials associated with ARD-103
NCT06680752
/ RecruitingPhase 1/2
A Phase 1/2, Open-label, Multicenter Trial to Assess the Safety and Efficacy of ARD103 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
100 Clinical Results associated with ARD-103
Login to view more data
100 Translational Medicine associated with ARD-103
Login to view more data
100 Patents (Medical) associated with ARD-103
Login to view more data
100 Deals associated with ARD-103
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Myelodysplastic SyndromesPhase 2
United States
Arce Therapeutics, Inc.
20 May 2025
Relapsing acute myeloid leukemiaPhase 2
United States
Arce Therapeutics, Inc.
20 May 2025
Acute Myeloid LeukemiaPreclinical
China
Arce Therapeutics, Inc.
03 Aug 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free